BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:UX-DA001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of UX-DA001\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06778265-1717@assetmemo.bio
DTSTAMP:20261121T005855Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:UX-DA001: Phase 1 readout est. (NCT06778265)
DESCRIPTION:UX-DA001\, phase 1\, Parkinson's Disease.\nStudy: An Explorator
 y Clinical Study of UX-DA001 in Subjects With Idiopathic Parkinson's Disea
 se\nEstimated primary completion: December 2027. This is a ClinicalTrials.
 gov estimate\, not a confirmed readout date\, and it can move.\nDrug page:
  https://assetmemo.bio/drug/ux-da001#upcoming-events\nRegistry record: htt
 ps://clinicaltrials.gov/study/NCT06778265
URL:https://assetmemo.bio/drug/ux-da001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
